Hunan Cancer Hospital, Radioactive Interventional Department

Changsha, Hunan 410013

0 studies enrolling now · 1 studies all time

What they study most

Hepatocellular Carcinoma (HCC)

Studies at this site

• A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma — Completed